Azenta announces resignation of chief accounting officer Violetta Hughes

Published 02/07/2025, 21:54
Azenta announces resignation of chief accounting officer Violetta Hughes

Azenta, Inc. (NASDAQ:AZTA), a life sciences company currently valued at $1.5 billion with an overall "GOOD" financial health rating according to InvestingPro, reported that Violetta Hughes, its Vice President and Chief Accounting Officer, has submitted her voluntary resignation. According to a statement released in a Securities and Exchange Commission filing, Ms. Hughes will leave her position, as well as all director and officer roles at the company’s subsidiaries, effective August 6, 2025.

The company stated that Ms. Hughes is departing to pursue opportunities outside of Azenta. The filing noted that her resignation is not the result of any disagreement with the company or its Board of Directors regarding operations, policies, practices, or any financial or accounting-related matters.

Ms. Hughes will remain with Azenta through her separation date to assist with the transition of her responsibilities.

This information is based on a press release statement contained in the company’s recent SEC filing.

In other recent news, Azenta Inc. reported its second-quarter fiscal year 2025 results, showing a revenue of $143 million, which slightly exceeded forecasts. However, the company’s earnings per share (EPS) came in at $0.05, falling short of the expected $0.08. Despite the EPS miss, Azenta’s revenue increased by 5% year-over-year, driven by strong performance in next-generation sequencing and PlasmaDZ. The company’s cash position remains robust at $540 million with no debt, highlighting financial stability. Azenta’s strategic focus on innovation and growth in the China market contributed to a 6% organic revenue growth. The company maintains its full-year guidance for organic revenue growth of 3-5% and aims for a 300 basis points expansion in EBITDA margin. Analysts noted the company’s resilience amid geopolitical tensions and funding challenges in the academic research market. Azenta continues to explore mergers and acquisitions to enhance growth and operational efficiency.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.